首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   26013篇
  免费   1711篇
  国内免费   720篇
耳鼻咽喉   61篇
儿科学   1517篇
妇产科学   138篇
基础医学   2076篇
口腔科学   108篇
临床医学   2727篇
内科学   4052篇
皮肤病学   330篇
神经病学   305篇
特种医学   1306篇
外科学   8401篇
综合类   2878篇
预防医学   898篇
眼科学   101篇
药学   1909篇
  9篇
中国医学   464篇
肿瘤学   1164篇
  2023年   408篇
  2022年   650篇
  2021年   919篇
  2020年   990篇
  2019年   1066篇
  2018年   1081篇
  2017年   984篇
  2016年   908篇
  2015年   898篇
  2014年   1666篇
  2013年   1669篇
  2012年   1448篇
  2011年   1461篇
  2010年   1227篇
  2009年   1307篇
  2008年   1325篇
  2007年   1258篇
  2006年   1154篇
  2005年   1037篇
  2004年   802篇
  2003年   691篇
  2002年   536篇
  2001年   511篇
  2000年   445篇
  1999年   352篇
  1998年   319篇
  1997年   281篇
  1996年   258篇
  1995年   279篇
  1994年   278篇
  1993年   211篇
  1992年   248篇
  1991年   181篇
  1990年   171篇
  1989年   141篇
  1988年   181篇
  1987年   126篇
  1986年   103篇
  1985年   96篇
  1984年   87篇
  1983年   43篇
  1982年   91篇
  1981年   72篇
  1980年   87篇
  1979年   67篇
  1978年   51篇
  1977年   52篇
  1976年   49篇
  1975年   30篇
  1973年   38篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
脂蛋白肾病(Lipoprotein glomerulopathy,LPG),1989年首次由日本学者Saito报道,LPG主要累及肾脏,且以肾小球病变为主[1]。几乎所有患者均有不同程度的蛋白尿,多数表现为肾病综合征,少数表现为轻微蛋白尿和镜下血尿,部分患者伴有不同程度的贫血及高血压,血脂异常易被忽略为肾病综合征的低蛋白血症所致。载脂蛋白E(apolipoprotein E,ApoE)增高是LPG血脂改变的主要特点[2-3]。LPG为一种与脂质代谢紊乱密切相关的肾脏疾病,目前世界范围内有报道的病例不足200例,儿童报道仅10余例[2]。本病进展缓慢,临床常误诊为原发性肾病综合征[4]。因此,为增强对LPG的认识,提高诊治水平,现分析1例确诊的儿童LPG临床资料,总结LPG的临床特点、诊断、治疗及预后。  相似文献   
12.
13.
14.
BackgroundConsiderable progress has been made in therapeutic options for multiple myeloma (MM). Understanding the current landscape of MM treatment options and associated outcomes in the real world is important in providing key insights into clinical and knowledge gaps which could be targeted for further optimization.MethodsThe Canadian Myeloma Research Group Database (CMRG-DB) is a prospectively maintained disease-specific database with >7000 patients. The objective of this study was to describe the trends in the treatment landscape and outcomes including early mortality, time to next treatment, and overall survival (OS) in each line of treatment stratified by autologous stem cell transplant (ASCT) receipt among newly-diagnosed MM patients in Canada between 2007 and 2018.ResultsA total of 5154 patients were identified among which 3030 patients (58.8%) received an upfront ASCT and 2124 (41.2%) did not. At diagnosis, the median age was 64 years and 58.6% were males. Bortezomib and lenalidomide were most frequently used (>50%) in first and second-line treatment respectively among both the ASCT and non-ASCT cohort. The median OS was 122.0 months (95% Cl 115.0-135.0 months) and 54.3 months (95% CI 50.8-58.8 months) for the ASCT and non-ASCT cohort respectively with an incremental decrease in OS in each subsequent line of treatment.ConclusionWe present the largest study to date in the Canadian landscape showing the characteristics, therapy usage, and outcomes among MM patients. This information will be critical in benchmarking current outcomes and provide key insight into areas of unmet needs and gaps for improvement of MM patients nationally.  相似文献   
15.
The purpose of this literature review is to investigate clinical treatment methods of total body irradiation within the context of a clinical department adopting a paediatric cohort with no existing technique. An extensive review of the literature was conducted using PubMed, Science Direct, Google Scholar, and Clinicians Knowledge Network. Articles were limited to nonhelical tomotherapy, nonparticle therapies, and those using hyperfractionated regimes. Total marrow irradiation was excluded because of national treatment and trial limitations. Of the numerous patient positioning methods present within the literature, the most comfortable and reproducible positioning methods for total body irradiation include both supine and the supine and/or prone combination. These positions increased stability and patient comfort during treatment, while also facilitating computed tomography data acquisition at the simulation stage. Ideally, dose calculations should be performed using a three-dimensional treatment planning system and quality assurance procedures that include in vivo dosimetry measurements. The available literature also suggests inhomogeneity correction factors and intensity modulation are superior to conventional open field techniques and should be implemented within developing protocols. Dynamic machine dose modulation is suggested to reduce department impact, removing the need for tissue compensators and accessory shielding devices, while providing significant improvements to treatment time and dose accuracy. Further long-term survival and intensity modulation studies are warranted, including direct comparisons of both dose modulation and treatment efficiency.  相似文献   
16.
17.
18.
19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号